Relay Therapeutics
- Market cap
- 3.93B
- P/E (TTM)i
- -11.51
- P/Bi
- 4.42
- EPSi
- -1.61
- Div yieldi
- 0.00%
- 52W posi
- 78%
Anonymous reader poll. Unscientific, not investment advice.
Relay Therapeutics shares were changing hands at 17.95, down 4.22% on the day. At current prices, the business is worth about 3.93B, the #2273 most valuable US-listed company we track. Across 9 analysts the consensus rating is Buy, with an average price target of 27.63 (+54%). Over the past year the stock has ranged from 5.85 to 21.27; it now sits 78% up that band.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 2% of the universe, above its 200-day average.
- Signal has read BUY for 6 months.
- Recent price momentum is +99.4% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 20.3% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 18.74
- Open
- 18.40
- Day range
- 17.85 - 18.54
- Avg price
- 18.04
- Volume
- 3.43M
- Turnover
- 61.94M
- Turnover ratei
- 2.36%
- Volume ratioi
- 1.13
- Amplitudei
- 3.68%
- 52-week rangei
- 5.85 - 21.27
Valuation
- P/Ei
- -11.15
- P/E (TTM)i
- -11.51
- P/Bi
- 4.42
- EPSi
- -1.61
- Book value / shi
- 4.06
- Net profit
- -352.82M
- Net assets
- 889.93M
Share structure
- Market cap
- 3.93B
- Float capi
- 2.61B
- Shares out
- 219.14M
- Float sharesi
- 145.48M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-07-16
15.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-31.97M net over the window
Short interest
- Shares short
- 44.49M
- % of floati
- 20.30%
- Days to coveri
- 14.22
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Relay Therapeutics (RLAY)?
Relay Therapeutics last traded at 17.95. The quote on this page refreshes every few seconds while US markets are open.
What is Relay Therapeutics's market cap?
About 3.93B.
What is the P/E ratio of Relay Therapeutics?
The trailing twelve-month P/E is -11.51. The Valuation tab shows it against the stock's own five-year range.
Does Relay Therapeutics pay a dividend?
Relay Therapeutics does not currently pay a regular dividend.
Is Relay Therapeutics a buy according to analysts?
The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 27.63, which implies 53.9% upside from the current price. This is not investment advice.
What is Relay Therapeutics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Relay Therapeutics a B (Buy). Twelve-month momentum in the top 2% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 07:00:27 · For reference only, not investment advice and not tailored to your situation.